John A. Morrow

2.7k citations

21 papers · 1.8k indexed · 1 hit paper · h-index 15

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments

Papers in ⓘ

Cellular and Molecular Neuroscience 15
- Neuroscience and Neuropharmacology Research 9
- Neuropeptides and Animal Physiology 6
Molecular Biology 13
- Receptor Mechanisms and Signaling 8
- Chemical Synthesis and Analysis 2

Co-authors: West Km (3 shared papers)Anthony J. Harmar (4 shared papers)E.M. Lutz (4 shared papers)George Fink (2 shared papers)W. John Sheward (1 shared paper)Matthew Fell (2 shared papers)Stephen Wilson (1 shared paper)Martin Steger (1 shared paper)
Journals: FEBS Letters (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Mini-Reviews in Medicinal Chemistry (1 paper)Brain Research (1 paper)
Partner nations: United Kingdom United States France

In The Last Decade

John A. Morrow

20 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases 2016 · 705 citations

Peers

Countries citing papers authored by John A. Morrow

Since Specialization

Citations

This map shows the geographic impact of John A. Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Morrow more than expected).

Fields of papers citing papers by John A. Morrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Morrow. The network helps show where John A. Morrow may publish in the future.

Co-authors

The 25 scholars most cited alongside John A. Morrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. Morrow Line = papers co-authored together John A. Morrow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases eLife ·Martin Steger, Francesca Tonelli, Genta Ito, Paul Davies, Matthias Trost, Melanie Vetter, Stefanie Wachter, Esben Lorentzen, Graham Duddy, Stephen Wilson, Marco A. S. Baptista, Brian Fiske, Matthew Fell, John A. Morrow, Alastair D. Reith, Dario R. Alessi, Matthias Mann Hit paper breakdown →	2016	705
2	The VIP₂ receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide FEBS Letters ·E.M. Lutz, W. John Sheward, West Km, John A. Morrow, George Fink, Anthony J. Harmar	1993	442
3	MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition Journal of Pharmacology and Experimental Therapeutics ·Matthew Fell, Christian Mirescu, Kallol Basu, Boonlert Cheewatrakoolpong, Duane E. DeMong, J. Michael Ellis, Lynn A. Hyde, Yinghui Lin, Carrie G. Markgraf, Hong Mei, Michael A. Miller, Frederique M. Poulet, Jack D. Scott, Michelle Smith, Zhizhang Yin, Xiaoping Zhou, Eric M. Parker, Matthew Kennedy, John A. Morrow	2015	206
4	Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP) FEBS Letters ·John A. Morrow, E.M. Lutz, West Km, George Fink, Anthony J. Harmar	1993	109
5	Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome¹ FEBS Letters ·John A. Morrow, Iain T. Collie, Donald R. Dunbar, Glenn Walker, Mansoor Shahid, David R. Hill	1998	56
6	Comparison of Alterations in c-fos and Egr-1 (zif268) Expression Throughout the Rat Brain Following Acute Administration of Different Classes of Antidepressant Compounds Neuropsychopharmacology ·David A. Slattery, John A. Morrow, Alan L. Hudson, David R. Hill, David Nutt, Brian Henry	2005	50
7	Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusion Cardiovascular Research ·Carlos Velasco, Edwin K. Jackson, John A. Morrow, João V. Vítola, Tadashi Inagami, Mervyn B. Forman	1993	34
8	A novel series of positive modulators of the AMPA receptor: Discovery and structure based hit-to-lead studies Bioorganic & Medicinal Chemistry Letters ·Craig Jamieson, Stephanie Basten, Robert A. Campbell, Iain Cumming, Kevin J. Gillen, Jonathan Gillespie, Bert Kazemier, Michael Kiczun, Yvonne Lamont, Amanda Lyons, John Maclean, Elizabeth M. Moir, John A. Morrow, Marianthi Papakosta, Zoran Ranković, Lynn Smith	2010	33
9	Positive Allosteric Modulators of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Journal of Medicinal Chemistry ·Simon J. A. Grove, Craig Jamieson, John Maclean, John A. Morrow, Zoran Ranković	2010	30
10	The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey Psychopharmacology ·Donnie Eddins, Terence G. Hamill, Vanita Puri, Christopher E. Cannon, Jeffrey A. Vivian, Sandra Sanabria Bohórquez, Jacquelynn J. Cook, John A. Morrow, Fiona Thomson, Jason M. Uslaner	2013	27
11	Structure based evolution of a novel series of positive modulators of the AMPA receptor Bioorganic & Medicinal Chemistry Letters ·Craig Jamieson, John Maclean, Christopher I. Brown, Robert A. Campbell, Kevin J. Gillen, Jonathan Gillespie, Bert Kazemier, Michael Kiczun, Yvonne Lamont, Amanda Lyons, Elizabeth M. Moir, John A. Morrow, John Pantling, Zoran Ranković, Lynn Smith	2010	24
12	Recent advances in positive allosteric modulators of the AMPA receptor. PubMed ·John A. Morrow, John Maclean, Craig Jamieson	2006	23
13	A novel series of positive modulators of the AMPA receptor: Structure-based lead optimization Bioorganic & Medicinal Chemistry Letters ·Craig Jamieson, Robert A. Campbell, Iain Cumming, Kevin J. Gillen, Jonathan Gillespie, Bert Kazemier, Michael Kiczun, Yvonne Lamont, Amanda Lyons, John Maclean, F Bachmann Martin, Elizabeth M. Moir, John A. Morrow, John Pantling, Zoran Ranković, Lynn Smith	2010	22
14	Domains determining agonist selectivity in chimaeric VIP₂ (VPAC₂)/PACAP (PAC₁) receptors British Journal of Pharmacology ·E.M. Lutz, Chris Mackenzie, Mary K. Johnson, West Km, John A. Morrow, Anthony J. Harmar, Richard W. Mitchell	1999	20
15	Antiglucocorticoids, Neurogenesis and Depression Mini-Reviews in Medicinal Chemistry ·Carlos P. Fitzsimons, Lenneke van Hooijdonk, John A. Morrow, B.W.M.M. Peeters, Niall M. Hamilton, Mark Craighead, Erno Vreugdenhil	2009	15
16	Respiratory alkalosis: no effect on blood lactate decline or exercise performance European Journal of Applied Physiology ·John A. Morrow, R. D. Fell, L. Bruce Gladden	1988	14
17	The rat vasoactive intestinal polypeptide cyclic AMP response element regulates gene transcriptional responses differently in neonatal and adult rat sensory neurons Neuroscience Letters ·Stephen P. Dobson, John P. Quinn, John A. Morrow, P.K. Mulderry	1994	10
18	Analysis of sequences important for herpes simplex virus type 1 latency-associated transcript promoter activity during lytic infection of tissue culture cells Journal of General Virology ·John A. Morrow, Frazer J. Rixon	1994	6
19	Therapeutic potential of potassium channel modulators for CNS disorders Expert Opinion on Therapeutic Patents ·Alan G. Clark, Susan E Booth, John A. Morrow	2003	6
20	Antinociceptive effects of potent, selective and brain penetrant muscarinic M4 positive allosteric modulators in rodent pain models Brain Research ·Steven M. Grauer, Raul Sanoja, Dominic Poulin, Harunor Rashid, Nina Jochnowitz, Michael E. Calhoun, Daniel Zwilling, Geoffrey B. Varty, Thomas W. Rosahl, Hamid Méziane, Christopher Mittlelhaeuser, Robert Mazzola, John A. Morrow, Sean M. Smith, Darrell A. Henze, Jacob Marcus	2020	2

About John A. Morrow

John A. Morrow is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Physiology, Spectroscopy and Neurology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (6 papers), Molecular Sensors and Ion Detection (4 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Hormonal Regulation and Hypertension (2 papers), Amino Acid Enzymes and Metabolism (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (891 citations), Neurology (658 citations), Cell Biology (355 citations), Reproductive Medicine (154 citations) and Neurology (134 citations). John A. Morrow has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include West Km, Anthony J. Harmar, E.M. Lutz, George Fink, W. John Sheward, Matthew Fell, Stephen Wilson, Martin Steger, Genta Ito and Stefanie Wachter. Their work appears in journals such as FEBS Letters, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Mini-Reviews in Medicinal Chemistry and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact